about
New Insight into Effects of β-Blockers on Arterial FunctionsDevelopment of a sustained-release microcapsule for delivery of metoprolol succinate.Controversial therapeutics: the β-adrenergic antagonist and cocaine-associated cardiovascular complications dilemma.The immune system and hypertension.Broad-scale phosphoprotein profiling of beta adrenergic receptor (β-AR) signaling reveals novel phosphorylation and dephosphorylation eventsRegulation of cardiac miR-208a, an inducer of obesity, by rapamycin and nebivolol.Chemogenetic and Optogenetic Activation of Gαs Signaling in the Basolateral Amygdala Induces Acute and Social Anxiety-Like StatesThe decline effect in cardiovascular medicine: is the effect of cardiovascular medicine and stent on cardiovascular events decline over the years?Pharmacology of myocardial calcium-handling.Cardioselective beta-blocker treatment of hypertension in patients with asthma: when do benefits outweigh risks?β-Adrenergic blockade in cardiovascular disease.Landiolol: a review of its use in intraoperative and postoperative tachyarrhythmias.A Comparison of Vasodilating and Non-vasodilating Beta-Blockers and Their Effects on Cardiometabolic Risk.β-Adrenergic modulation of cancer cell proliferation: available evidence and clinical perspectives.Therapies to Reduce Blood Pressure Acutely.Beta-Blockers and Calcium Channel Blockers: First Line Agents.Hypertension-induced remodelling: on the interactions of cardiac risk factors.CYP2C19 genotype has a major influence on labetalol pharmacokinetics in healthy male Chinese subjects.Beta-adrenergic stimulation maintains cardiac function in Serca2 knockout mice.Antihypertensive drugs and the risk of incident rosacea.Sublethal effects of the beta-blocker sotalol at environmentally relevant concentrations on the New Zealand mudsnail Potamopyrgus antipodarum.Mechanisms in hypertension and target organ damage: Is the role of the thymus key? (Review).
P2860
Q26747936-6AFF4682-154B-4664-BF78-1F08D098C896Q33724260-86406AC7-053A-406B-B7ED-18DAD0490DB1Q34438864-768FB457-057F-4020-A11B-D18C8F102499Q35038155-8894FA4B-3D21-49FF-990A-454DFD9E4790Q35067711-B48328A3-791A-4E8E-9F82-E2FAC22B3E12Q36249066-F079CEE6-FDBC-4EA1-B0BB-EC1F3E4AF54CQ37006297-6649D77F-9569-4CE2-97A1-913AA2C9643FQ37098181-66071060-D25B-4891-889E-A41EDAB50DF6Q38019446-BE3E7011-ECFE-4901-ABAA-3C950349A9C4Q38043049-93D6C9F2-23BB-498C-8084-A6C08FA95219Q38103516-F69FB699-E57F-4719-8ED5-2DE773FE0620Q38113979-971EF50E-95B6-4A2E-A9F5-4154B8C36D53Q38433805-17FB32B5-EF0B-4E37-9D3E-8F8BF1AEF39AQ38742275-B7B329F7-3E0C-42DE-A701-BB54C5D52E51Q38820114-87113402-2BFC-4491-893D-9CC771198F03Q38941375-7634EEAD-FF93-45A3-BAD9-FC7A3066F9C1Q39144071-8D2DE0CD-EE32-4D57-BB88-7FD4BD73E5ADQ39532194-060F9124-FAAA-4362-9F83-CACB5EA9476CQ41841957-F118D0FE-95AB-4C1E-B5F6-B90A37E9BA55Q44804086-E425CE4C-2CDF-492E-AAD2-4334F312D198Q46851083-8CB2A20C-6614-4C91-8BF9-589F74C587AEQ55032413-6E2DEF51-0D0B-42AD-BAF7-3C2EEE2FA707
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
β-Adrenergic blockers.
@en
β-Adrenergic blockers.
@nl
type
label
β-Adrenergic blockers.
@en
β-Adrenergic blockers.
@nl
prefLabel
β-Adrenergic blockers.
@en
β-Adrenergic blockers.
@nl
P2860
P1476
β-Adrenergic blockers.
@en
P2093
Elijah Saunders
William H Frishman
P2860
P304
P356
10.1111/J.1751-7176.2011.00515.X
P577
2011-08-08T00:00:00Z